APT Medical (SHSE:688617) Shares Outstanding (EOP): 142 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688617 APT Medical Inc SHSE:688617
78 GF Score
Price ¥239.60
GF Value ¥366.17
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is APT Medical Shares Outstanding (EOP)?

APT Medical SHSE:688617 -1.35% 78 Shares Outstanding (EOP) is 142 Mil as of Jun. 2026. GuruFocus rates SHSE:688617 with a GF Score™ of 78/100 and a GF Value™ of ¥366.17 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. APT Medical's shares outstanding for the quarter that ended in Jun. 2026 was 142 Mil.

APT Medical's quarterly shares outstanding increased from Mar. 2026 (141 Mil) to Jun. 2026 (142 Mil). It means APT Medical issued new shares from Mar. 2026 to Jun. 2026 .

APT Medical's annual shares outstanding declined from Dec. 2024 (141 Mil) to Dec. 2025 (141 Mil). It means APT Medical bought back shares from Dec. 2024 to Dec. 2025 .


APT Medical  (SHSE:688617) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


APT Medical Shares Outstanding (EOP) Related Terms


APT Medical Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for APT Medical's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

APT Medical Shares Outstanding (EOP) Chart

APT Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only 140.17 140.17 140.58 141.22 141.03

APT Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.01 141.03 141.03 141.04 141.53

SHSE:688617 vs ABT, SYK, MDT: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, APT Medical's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


APT Medical Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where APT Medical's Shares Outstanding (EOP) falls into.


SHSE:688617
78GF Score
APT Medical Inc SHSE:688617
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

APT Medical Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 142 Mil mean?
APT Medical (SHSE:688617) has a Shares Outstanding (EOP) of 142 Mil as of Jun. 2026. The total shares a company has outstanding, at period-end. View historical data on APT Medical and its competitors.
Is APT Medical's Shares Outstanding (EOP) too high?
APT Medical's current Shares Outstanding (EOP) is 142 Mil. Overall, APT Medical has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does APT Medical's Shares Outstanding (EOP) compare to ABT and SYK?
APT Medical's Shares Outstanding (EOP) of 142 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on APT Medical and its competitors. APT Medical's current Shares Outstanding (EOP) is 142 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is APT Medical stock overvalued right now?
Based on GuruFocus' analysis, APT Medical (SHSE:688617) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥366.17, compared to a current price of ¥239.60 — trading 34.6% below its estimated fair value. The current Shares Outstanding (EOP) is 142 Mil. APT Medical's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For APT Medical (SHSE:688617), the current Shares Outstanding (EOP) is 142 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is APT Medical (SHSE:688617) Overvalued in 2026?

Based on GuruFocus' analysis, APT Medical stock appears to be undervalued. The current stock price of ¥239.60 is trading 34.6% below its estimated GF Value™ of ¥366.17. GuruFocus considers APT Medical to be Significantly Undervalued.

Key valuation signals for SHSE:688617:

  • Shares Outstanding (EOP): 142 Mil
  • GF Value™: ¥366.17 vs. price of ¥239.60 (34.6% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the SHSE:688617 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


APT Medical Business Description

Address No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
78GF Score

Get the complete analysis for SHSE:688617

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥239.60
Price
¥366.17
GF Value